Stockholders' Equity |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | 9. Stockholders’ Equity Dividends On March 12, 2026, the Company’s Board of Directors (the “Board”) declared a dividend for the quarter ending March 31, 2026 of $0.015 per share payable on April 2, 2026 to holders of the Company’s common stock as of March 23, 2026. As of March 31, 2026, the Company recorded a dividend payable of $3.0 million which is included within accounts payable and other current liabilities in the condensed consolidated balance sheets. Dividend activity for the first quarter of 2025 was as follows:
Share Repurchases October 2024 Share Repurchase Program Extension and Expansion On October 29, 2024, the Board approved an extension and expansion of its share repurchase program, which allowed for the repurchase of up to $25.0 million of the Company’s common stock through December 31, 2025, subject to early termination or extension by the Board. The Company repurchased 2,029,445 shares for $8.8 million during the three months ended March 31, 2025 under this repurchase program. April 2025 Share Repurchase Program Expansion On April 30, 2025, the Board approved a further expansion of its share repurchase program, which allowed for the repurchase of up to $25.0 million of the Company’s common stock through December 31, 2025, subject to early termination or extension by the Board. October 2025 Share Repurchase Program Extension and Expansion (“October 2025 Share Repurchase Program”) On October 30, 2025, the Board approved an extension and expansion of its share repurchase program, which allows for the repurchase of up to $25.0 million of the Company’s common stock through December 31, 2026, subject to early termination or extension by the Board. The Company did not repurchase any shares during the three months ended March 31, 2026 under this extension and expansion. There was $24.6 million remaining available for share repurchases under the October 2025 Share Repurchase Program as of March 31, 2026. The share repurchase program may be suspended or discontinued at any time without notice. Accumulated Other Comprehensive Income (Loss) The Company reports other comprehensive income (loss) and its components in its condensed consolidated financial statements. Comprehensive income (loss) consists of net income (loss) and foreign currency translation adjustments affecting stockholders’ equity that, under U.S. GAAP, is excluded from net income (loss). The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the three months ended March 31, 2026:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||